Kabra Drugs informs about financial results

02 Feb 2019 Evaluate

In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), Kabra Drugs has informed that the Unaudited Financial Results (Standalone) of the Company for the Quarter and Half-Year ended December 31, 2018 were approved by the Board of Directors of the Company at its meeting held.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

7.19 0.00 (0.00%)
22-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1506.10
Dr. Reddys Lab 6244.50
Cipla 1407.80
Zydus Lifesciences 946.50
Lupin 1614.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.